CARLA DAVIS to Administration, Oral
This is a "connection" page, showing publications CARLA DAVIS has written about Administration, Oral.
Connection Strength
0.860
-
Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). J Allergy Clin Immunol Pract. 2022 02; 10(2):566-576.e6.
Score: 0.166
-
Shrimp-allergic patients in a multi-food oral immunotherapy trial. Pediatr Allergy Immunol. 2022 01; 33(1):e13679.
Score: 0.165
-
Memory and na?ve gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapy. Clin Immunol. 2021 09; 230:108820.
Score: 0.162
-
Oral allergy syndrome in shrimp and house dust mite allergies. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2163-2164.
Score: 0.130
-
Peanut oral immunotherapy dose variations do not result in allergic reactions. Pediatr Allergy Immunol. 2018 03; 29(2):218-220.
Score: 0.127
-
Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy. Ann Allergy Asthma Immunol. 2020 08; 125(2):196-201.e1.
Score: 0.037
-
The clinical and immune outcomes after food allergen immunotherapy emphasizing the development of tolerance. Curr Opin Pediatr. 2019 12; 31(6):821-827.
Score: 0.036
-
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 04; 145(4):1153-1156.
Score: 0.036